Drug Approval | July 31, 2022
Casper Pharma completed USFDA pre-approval inspection
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
The financial assistance by the centre is subject to a maximum limit of Rs.1000 crore per park
The product will be manufactured at Lupin's facility in Nagpur, India.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Merck’s first microbiology application and training lab in India
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Subscribe To Our Newsletter & Stay Updated
